Moreover, silencing CD70 downregulated stem-related markers (CD44 and SOX-2), inhibited tumor growth and migration, promoted immune suppression by attracting monocyte-derived M2 macrophages, further highlighting its therapeutic potential [134]. The gene discussed is CD44; the disease is neoplasm.